BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784 [PMID: 28487615 DOI: 10.3748/wjg.v23.i15.2771]
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2771.htm
Number Citing Articles
1
Kara Wegermann, Catherine Howe, Ricardo Henao, Ying Wang, Cynthia D. Guy, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan. Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver DiseaseHepatology Communications 2021; 5(4): 608 doi: 10.1002/hep4.1665
2
Zohre Mozduri, Nathalie Marty-Gasset, Bara Lo, Ali Akbar Masoudi, Mireille Morisson, Cécile Canlet, Julien Arroyo, Agnès Bonnet, Cécile M. D. Bonnefont. Identification of Plasmatic Biomarkers of Foie Gras Qualities in Duck by MetabolomicsFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.628264
3
Yuri A. Lawrence, Blake C. Guard, Jörg M. Steiner, Jan S. Suchodolski, Jonathan A. Lidbury, Juan J. Loor. Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic diseasePLOS ONE 2019; 14(5): e0217797 doi: 10.1371/journal.pone.0217797
4
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, Jun Yu. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancerCancer Letters 2019; 459: 186 doi: 10.1016/j.canlet.2019.114425
5
Qian Feng, Yuanmeng Li, Yuwei Yang, Jiafu Feng. Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney DiseaseFrontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.578799
6
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)Metabolites 2019; 9(2): 25 doi: 10.3390/metabo9020025
7
Aihua Zhang, Qiang Yang, Hui Sun, Xijun Wang. Mass Spectrometry‐Based Metabolomics in Clinical and Herbal Medicines2021; : 1 doi: 10.1002/9783527835751.ch1
8
Dragana Savic, Leanne Hodson, Stefan Neubauer, Michael Pavlides. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)Nutrients 2020; 12(8): 2178 doi: 10.3390/nu12082178
9
Tao Tang, Ya Li, Jie Wang, Mauricio A. Elzo, Jiahao Shao, Yanhong Li, Siqi Xia, Huimei Fan, Xianbo Jia, Songjia Lai. Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in Rabbits Fed an Antibiotic-Free DietAnimals 2021; 11(6): 1560 doi: 10.3390/ani11061560
10
Eugenia Carril, María Pilar Valdecantos, Borja Lanzón, Santiago Angulo, Ángela M. Valverde, Joanna Godzien, Francisco Javier Rupérez. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient dietJournal of Pharmaceutical and Biomedical Analysis 2020; 178: 112958 doi: 10.1016/j.jpba.2019.112958
11
Lars Ove Dragsted, Kajetan Trošt. The Human Gut-Liver-Axis in Health and Disease2019; : 147 doi: 10.1007/978-3-319-98890-0_10
12
George N. Ioannou, G. A. Nagana Gowda, Danijel Djukovic, Daniel Raftery. Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics ApproachMetabolites 2020; 10(4): 168 doi: 10.3390/metabo10040168
13
Jose Rodríguez-Morató, Óscar J Pozo, Josep Marcos. Targeting human urinary metabolome by LC–MS/MS: a reviewBioanalysis 2018; 10(7): 489 doi: 10.4155/bio-2017-0285
14
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, Enara Arretxe, Cristina Alonso, Melania Gaggini, Julia Brosnan, Quentin M. Anstee, Oscar Millet, Pablo Ortiz, Jose M. Mato, Jean-Francois Dufour, Matej Orešič. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic testsNature Reviews Gastroenterology & Hepatology 2021;  doi: 10.1038/s41575-021-00502-9
15
Xiao-jun Gou, Shanshan Gao, Liang Chen, Qin Feng, Yi-yang Hu. A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat DietBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5920485
16
Brianna Cyr, Robert W. Keane, Juan Pablo de Rivero Vaccari. ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept StudyInternational Journal of Molecular Sciences 2020; 21(22): 8580 doi: 10.3390/ijms21228580
17
Application of Metabolomics in Diagnosis and Treatment of Chronic Liver DiseasesCritical Reviews in Analytical Chemistry 2020; : 1 doi: 10.1080/10408347.2020.1842172
18
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH2020; : 181 doi: 10.1007/978-3-030-37173-9_10
19
David S. Wishart. Metabolomics for Investigating Physiological and Pathophysiological ProcessesPhysiological Reviews 2019; 99(4): 1819 doi: 10.1152/physrev.00035.2018
20
Mingzhe Zhu, Meng Li, Wenjun Zhou, Guangbo Ge, Li Zhang, Guang Ji. Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia RatsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00671
21
Diren Beyoğlu, Jeffrey R. Idle. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and TherapyMetabolites 2020; 10(2): 50 doi: 10.3390/metabo10020050
22
Xiangnan Ren, Wu Fan, Zixing Shao, Kaiyun Chen, Xuefeng Yu, Qionglin Liang. A metabolomic study on early detection of steroid-induced avascular necrosis of the femoral headOncotarget 2018; 9(8): 7984 doi: 10.18632/oncotarget.24150
23
Stefano Gitto, Filippo Schepis, Pietro Andreone, Erica Villa. Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical PerspectivesMetabolites 2018; 8(1): 17 doi: 10.3390/metabo8010017
24
Huikuan Chu, Yi Duan, Ling Yang, Bernd Schnabl. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver diseaseGut 2019; 68(2): 359 doi: 10.1136/gutjnl-2018-316307
25
Liyan Liu, Jinhui Zhao, Runan Zhang, Xuemei Wang, Yan Wang, Yang Chen, Rennan Feng. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver diseaseJournal of Pharmaceutical and Biomedical Analysis 2021; 200: 114058 doi: 10.1016/j.jpba.2021.114058
26
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, Jinho Yang, Yoon-Keun Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Jae-Yong Chung, Joo-Youn Cho. Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30349-1
27
Qiang Yang, Ai-hua Zhang, Jian-hua Miao, Hui Sun, Ying Han, Guang-li Yan, Fang-fang Wu, Xi-jun Wang. Metabolomics biotechnology, applications, and future trends: a systematic reviewRSC Advances 2019; 9(64): 37245 doi: 10.1039/C9RA06697G
28
Wei-Wei Li, Yan Yang, Qi-Gang Dai, Li-Li Lin, Tong Xie, Li-Li He, Jia-Lei Tao, Jin-Jun Shan, Shou-Chuan Wang. Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndromeMetabolomics 2018; 14(7) doi: 10.1007/s11306-018-1387-z
29
Ahmad Moolla, Jasper de Boer, David Pavlov, Amin Amin, Angela Taylor, Lorna Gilligan, Beverly Hughes, John Ryan, Eleanor Barnes, Zaki Hassan-Smith, Jane Grove, Guruprasad P. Aithal, An Verrijken, Sven Francque, Luc Van Gaal, Matthew J. Armstrong, Phillip N. Newsome, Jeremy F. Cobbold, Wiebke Arlt, Michael Biehl, Jeremy W. Tomlinson. Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolomeAlimentary Pharmacology & Therapeutics 2020; 51(11): 1188 doi: 10.1111/apt.15710
30
Maria Del Ben, Diletta Overi, Licia Polimeni, Guido Carpino, Giancarlo Labbadia, Francesco Baratta, Daniele Pastori, Valeria Noce, Eugenio Gaudio, Francesco Angelico, Carmine Mancone. Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASHInternational Journal of Molecular Sciences 2018; 19(2): 603 doi: 10.3390/ijms19020603
31
Elisa Gurian, Pablo Giraudi, Natalia Rosso, Claudio Tiribelli, Deborah Bonazza, Fabrizio Zanconati, Michela Giuricin, Silvia Palmisano, Nicolò de Manzini, Valter Sergo, Alois Bonifacio. Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopyAnalytica Chimica Acta 2020; 1110: 190 doi: 10.1016/j.aca.2020.02.040